Stock Comparison
REGN vs TECH
Regeneron Pharmaceuticals Inc and Bio-Techne Corp side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$80.55B
$11.27B
P/E (TTM)
19.4
103.3
Forward P/E
17.1
34.5
Price/Sales
5.2
9.3
Price/Book
2.5
5.4
EV/EBITDA
13.1
44.1
Dividend Yield
0.45%
0.44%
Profitability
Net Margin
29.65%
9.05%
Operating Margin
24.32%
12.70%
Return on Equity
14.00%
5.34%
Return on Assets
6.53%
7.45%
Growth (YoY)
Revenue Growth
16.70%
-1.50%
Earnings Growth
-4.50%
128.60%
Price & Risk
Beta
0.2
1.3
52-Week High
$810.12
$72.29
52-Week Low
$553.38
$43.22
Analyst Target
$833.54
$69.73
Compare REGN and TECH your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.